CLBH589DUS108T: Panobinostat With Carfilzomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Correlation With In Vitro Chemosensitivity Testing
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone (Primary) ; Panobinostat (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms CLBH589DUS108T
- 14 Nov 2017 Planned initiation date changed from 31 Oct 2017 to 31 Dec 2017.
- 25 Sep 2017 Planned initiation date changed from 16 Sep 2017 to 31 Oct 2017.
- 24 Aug 2017 New trial record